Lrrk2tm1.1Dral
Targeted Allele Detail
|
|
| Symbol: |
Lrrk2tm1.1Dral |
| Name: |
leucine-rich repeat kinase 2; targeted mutation 1.1, Dario R Alessi |
| MGI ID: |
MGI:7865614 |
| Gene: |
Lrrk2 Location: Chr15:91557378-91700323 bp, + strand Genetic Position: Chr15, 46.07 cM, cytoband F1
|
| Alliance: |
Lrrk2tm1.1Dral page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:101977
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
|
| Allele Type: |
|
Targeted (Conditional ready) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details:
The allele was designed to incorporate a conditional R1441G point mutation into exon 31 of the leucine-rich repeat kinase 2 (Lrrk2) gene. The targeting vector, which was inserted into the endogenous Lrrk2 intron 30, consists of an initial loxP site, followed by an FRT-flanked neomycin cassette, exons31-51 Lrrk2 cDNA including the 3' untranslated region (UTR), an hGHpA (2.1 kb of the human growth hormone gene harboring the hGH polyadenylation signal), an F3-flanked puromycin cassette, and a second loxP site. Genomic exon 31 harboring the R1441G mutation is located immediately downstream of the second loxP site. FLP-recombinase removed the FRT-flanked neomycin cassette and the F3-flanked puromycin cassette.
(J:101977)
|
|
|
|
|
| Original: |
J:101977 The Jackson Laboratory, Information obtained from The Jackson Laboratory, Bar Harbor, ME. Unpublished. 2005-2017; |
| All: |
1 reference(s) |
|